Connecticare requires Genetic testing to be pre-authorized
The most common tests requiring pre-authorization include:
- Cytochrome CYP P450 testing:
- CYP 450 2C19
- CYP 450 2C9
- CYP 450 2D6
- Warfarin/Coumadin Sensitivity
- Hemochromatosis
- Factor V Leiden
- Fragile X (with reflex)
- MTHFR Gene Mutation
- Ashkenazi Jewish Panel
- Prothrombin Factor II mutation
- Antithrombin III Activity
- Alpha-1 Antitrypsin (AAT)
- Tay –Sachs (Ashkenazi)
- Gaucher Disease Mutation
- Canavan Disease Mutation
The following tests do not require pre-authorization:
- Routine chromosomal analysis (e.g., peripheral blood, tissue culture, chorionic villous sampling, amniocentesis)
- DNA testing for cystic fibrosis
- FISH (fluorescent in situ hybridization) for diagnosis of lymphoma or leukemia
For additional information, please contact:
Connecticare Provider Services at 1-800-828-3407 or http://www.connecticare.com/.
Clinical Laboratory Partners Connecticare representative at 860-696-8209. |
|